Fintel reports that on October 16, 2024, Maxim Group downgraded their outlook for Helius Medical Technologies (NasdaqCM:HSDT) ...
Maxim Group analyst Michael Diana maintained a Hold rating on Westamerica Bancorporation (WABC – Research Report) yesterday. The ...
On Friday, Beyond Inc (BYON) stock saw a modest uptick, ending the day at $10.52 which represents a slight increase of $0.41 or 4.06% from the prior close of $10.11. The stock opened at $10.24 and ...
(PBI) stock saw a modest uptick, ending the day at $7.15 which represents a slight increase of $0.09 or 1.27% from the prior close of $7.06. The stock opened at $7.08 and touched a low of $6.97 during ...
Maxim Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key reason for ...
Fintel reports that on October 16, 2024, Maxim Group initiated coverage of GameSquare Holdings (NasdaqCM:GAME) with a Buy recommendation. Analyst Price Forecast Suggests 628.57% Upside As of ...
Tuesday, Maxim Group began coverage on shares of Ocugen, Inc. (NASDAQ: NASDAQ:OCGN), issuing a Buy rating and setting a price target of $4.00. The firm highlighted Ocugen's financial position ...
Fintel reports that on October 16, 2024, Maxim Group downgraded their outlook for Helius Medical Technologies (MUN:26H) from Buy to Hold. There are 19 funds or institutions reporting positions in ...
Maxim (NASDAQ:MXIM) Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key ...
Horizon Space Acquisition II, a blank-check company, filed for a $60 million initial public offering on Monday. The company said it has significant ties to China, and while it hasn't limited its ...
Shares of AGNC Investment Corp. (NASDAQ:AGNC – Get Free Report) have received an average recommendation of “Moderate Buy” ...
Tuesday, Maxim (NASDAQ:MXIM) Group began coverage on shares of Ocugen, Inc. (NASDAQ: NASDAQ:OCGN), issuing a Buy rating and setting a price target of $4.00. The firm highlighted Ocugen's financial ...